![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 1 | BIOSPECIFICS TECHNOLOGIES CORP | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 357.51% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 2 | SPRING PHARMACEUTICAL GROUP INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 355.04% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001177648_256x256.png) | 3 | ENANTA PHARMACEUTICALS INC | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 332.14% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001232524_256x256.png) | 4 | Jazz Pharmaceuticals plc | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 323.69% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001485003_256x256.png) | 5 | Carisma Therapeutics Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 322.16% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000827871_256x256.png) | 6 | EAGLE PHARMACEUTICALS INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 297.41% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 7 | ACHILLION PHARMACEUTICALS INC | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 292.07% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001082554_256x256.png) | 8 | UNITED THERAPEUTICS Corp | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 281.00% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000863894_256x256.png) | 9 | VERU INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 271.09% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001551152_256x256.png) | 10 | AbbVie Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 270.97% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000001800_256x256.png) | 11 | ABBOTT LABORATORIES | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 270.46% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001596783_256x256.png) | 12 | Catalent Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 269.32% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001117480_256x256.png) | 13 | CHIMERIX INC | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 268.32% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001557746_256x256.png) | 14 | Aclaris Therapeutics Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 266.46% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 15 | FIVE PRIME THERAPEUTICS INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 262.30% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000886744_256x256.png) | 16 | GERON CORP | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 262.15% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 17 | Corvus Pharmaceuticals Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 260.40% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001404644_256x256.png) | 18 | Neoleukin Therapeutics Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 258.24% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 19 | ENDOCYTE INC | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 256.30% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 20 | Ra Pharmaceuticals Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 253.29% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001309057_256x256.png) | 21 | China Health Industries Holdings Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 249.76% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000310158_256x256.png) | 22 | Merck & Co. Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 244.89% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001659617_256x256.png) | 23 | Moleculin Biotech Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 244.66% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001582313_256x256.png) | 24 | Xenon Pharmaceuticals Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 244.57% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001636282_256x256.png) | 25 | Aeglea BioTherapeutics Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 243.40% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001434868_256x256.png) | 26 | Esperion Therapeutics Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 243.20% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001178879_256x256.png) | 27 | AMICUS THERAPEUTICS INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 242.82% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000318306_256x256.png) | 28 | ABEONA THERAPEUTICS INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 241.55% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001583107_256x256.png) | 29 | Theravance Biopharma Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 239.36% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001540159_256x256.png) | 30 | Edesa Biotech Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 238.24% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001597264_256x256.png) | 31 | Blueprint Medicines Corp | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 234.41% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 32 | ZOGENIX INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 233.15% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 33 | ALDER BIOPHARMACEUTICALS INC | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 230.69% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001125345_256x256.png) | 34 | MACROGENICS INC | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 228.24% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001527599_256x256.png) | 35 | SYNLOGIC INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 228.11% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 36 | Pfenex Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 227.33% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001041024_256x256.png) | 37 | ROCKWELL MEDICAL INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 226.75% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001369568_256x256.png) | 38 | CATALYST PHARMACEUTICALS INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 224.64% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 39 | Assertio Therapeutics Inc | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 224.16% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001087294_256x256.png) | 40 | CUMBERLAND PHARMACEUTICALS INC | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 219.48% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 41 | Adamas Pharmaceuticals Inc | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 219.01% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001297184_256x256.png) | 42 | Amphastar Pharmaceuticals Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 218.82% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001226616_256x256.png) | 43 | MEDICINOVA INC | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 215.25% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001374690_256x256.png) | 44 | Larimar Therapeutics Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 214.19% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001651308_256x256.png) | 45 | BeiGene Ltd. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 212.86% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001571498_256x256.png) | 46 | Epizyme Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 209.26% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000944809_256x256.png) | 47 | OPKO HEALTH INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 207.51% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001326732_256x256.png) | 48 | Xencor Inc | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 207.36% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001567514_256x256.png) | 49 | Intra-Cellular Therapies Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 205.92% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001070494_256x256.png) | 50 | ACADIA PHARMACEUTICALS INC | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 205.44% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001445283_256x256.png) | 51 | KINETA INC. DE | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 204.04% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001318641_256x256.png) | 52 | Statera Biopharma Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 203.49% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001631574_256x256.png) | 53 | Wave Life Sciences Ltd. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 203.27% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001439222_256x256.png) | 54 | AGIOS PHARMACEUTICALS INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 201.91% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 55 | Cellectar Biosciences Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 199.99% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 56 | TENAX THERAPEUTICS INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 199.24% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001539029_256x256.png) | 57 | Clearside Biomedical Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 198.77% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001593034_256x256.png) | 58 | Endo International plc | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 197.40% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001356576_256x256.png) | 59 | SUPERNUS PHARMACEUTICALS INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 197.12% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001493566_256x256.png) | 60 | OTONOMY INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 196.84% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 61 | JUNIPER PHARMACEUTICALS INC | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 196.12% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 62 | Neurotrope Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 195.38% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000764195_256x256.png) | 63 | VBI Vaccines Inc BC | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 190.33% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001680048_256x256.png) | 64 | MUSTANG BIO INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 189.45% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001598646_256x256.png) | 65 | Minerva Neurosciences Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 189.17% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 66 | CAMBREX CORP | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 189.17% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001437402_256x256.png) | 67 | ARDELYX INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 188.58% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 68 | Flexion Therapeutics Inc | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 188.19% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001626199_256x256.png) | 69 | ALPINE IMMUNE SCIENCES INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 186.68% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001479290_256x256.png) | 70 | Revance Therapeutics Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 185.88% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 71 | MyoKardia Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 184.20% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001556263_256x256.png) | 72 | Syros Pharmaceuticals Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 184.12% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001267602_256x256.png) | 73 | ALIMERA SCIENCES INC | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 181.13% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001535955_256x256.png) | 74 | Lipocine Inc. | | 179.91% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000872589_256x256.png) | 75 | REGENERON PHARMACEUTICALS INC. | | 179.78% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 76 | Dermira Inc. | | 178.02% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 77 | ALEXION PHARMACEUTICALS INC. | | 172.38% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001069530_256x256.png) | 78 | CASSAVA SCIENCES INC | | 172.34% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 79 | Kura Oncology Inc. | | 169.88% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001522602_256x256.png) | 80 | CohBar Inc. | | 169.64% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001559053_256x256.png) | 81 | PROTHENA CORP PUBLIC LTD CO | | 168.93% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001261249_256x256.png) | 82 | AGILE THERAPEUTICS INC | | 168.34% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001367920_256x256.png) | 83 | CONCERT PHARMACEUTICALS INC. | | 167.54% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001651407_256x256.png) | 84 | Checkpoint Therapeutics Inc. | | 166.98% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000768710_256x256.png) | 85 | RELIV INTERNATIONAL INC | | 165.43% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001088856_256x256.png) | 86 | CORCEPT THERAPEUTICS INC | | 165.02% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000025743_256x256.png) | 87 | TherapeuticsMD Inc. | | 164.37% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 88 | IMMUNE DESIGN CORP. | | 164.35% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000275053_256x256.png) | 89 | NATURES SUNSHINE PRODUCTS INC | | 163.87% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 90 | Allergan plc | | 160.39% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001496671_256x256.png) | 91 | Calithera Biosciences Inc. | | 160.38% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001367644_256x256.png) | 92 | Emergent BioSolutions Inc. | | 160.18% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 93 | CHIASMA INC | | 160.17% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001228627_256x256.png) | 94 | Ocuphire Pharma Inc. | | 160.08% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000886163_256x256.png) | 95 | LIGAND PHARMACEUTICALS INC | | 152.62% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001322505_256x256.png) | 96 | ALBIREO PHARMA INC. | | 152.49% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001544227_256x256.png) | 97 | Tempest Therapeutics Inc. | | 151.87% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 98 | Citius Pharmaceuticals Inc. | | 151.41% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001395937_256x256.png) | 99 | Syndax Pharmaceuticals Inc | | 149.77% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001005286_256x256.png) | 100 | LIFECORE BIOMEDICAL INC. \DE\ | | 149.05% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001267565_256x256.png) | 101 | COLLEGIUM PHARMACEUTICAL INC | | 145.79% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001061983_256x256.png) | 102 | CYTOKINETICS INC | | 145.37% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 103 | NeuroBo Pharmaceuticals Inc. | | 144.76% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000812796_256x256.png) | 104 | SOLIGENIX INC. | | 144.29% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001178670_256x256.png) | 105 | ALNYLAM PHARMACEUTICALS INC. | | 143.74% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001347178_256x256.png) | 106 | Vanda Pharmaceuticals Inc. | | 143.66% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 107 | Nabriva Therapeutics plc | | 142.85% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001553643_256x256.png) | 108 | RELMADA THERAPEUTICS INC. | | 135.93% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001092662_256x256.png) | 109 | CHEMBIO DIAGNOSTICS INC. | | 134.98% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 110 | ARENA PHARMACEUTICALS INC | | 134.97% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001113148_256x256.png) | 111 | INFINITY PHARMACEUTICALS INC. | | 132.30% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001438533_256x256.png) | 112 | Travere Therapeutics Inc. | | 129.66% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001636050_256x256.png) | 113 | Sio Gene Therapies Inc. | | 129.08% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001626878_256x256.png) | 114 | XBiotech Inc. | | 127.78% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000014272_256x256.png) | 115 | BRISTOL MYERS SQUIBB CO | | 127.60% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001621443_256x256.png) | 116 | Zynerba Pharmaceuticals Inc. | | 126.38% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001513818_256x256.png) | 117 | Aravive Inc. | | 126.00% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001023024_256x256.png) | 118 | ANI PHARMACEUTICALS INC | | 124.24% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 119 | TESARO Inc. | | 123.98% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000873303_256x256.png) | 120 | Sarepta Therapeutics Inc. | | 121.93% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001533040_256x256.png) | 121 | Phio Pharmaceuticals Corp. | | 121.42% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001100397_256x256.png) | 122 | Ayala Pharmaceuticals Inc. | | 120.34% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001253689_256x256.png) | 123 | GLYCOMIMETICS INC | | 116.86% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001358403_256x256.png) | 124 | BELLICUM PHARMACEUTICALS INC | | 115.66% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 125 | NANOVIRICIDES INC. | | 115.17% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 126 | ARATANA THERAPEUTICS INC. | | 114.54% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001176309_256x256.png) | 127 | ORAMED PHARMACEUTICALS INC. | | 113.86% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 128 | Oncternal Therapeutics Inc. | | 113.27% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000831547_256x256.png) | 129 | SPECTRUM PHARMACEUTICALS INC | | 109.19% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 130 | Evofem Biosciences Inc. | | 108.97% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001326190_256x256.png) | 131 | Altimmune Inc. | | 105.73% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 132 | AKORN INC | | 101.71% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 133 | Achaogen Inc. | | 101.65% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000879407_256x256.png) | 134 | ARROWHEAD PHARMACEUTICALS INC. | | 101.40% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000875320_256x256.png) | 135 | VERTEX PHARMACEUTICALS INC MA | | 99.35% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000887247_256x256.png) | 136 | DMK PHARMACEUTICALS Corp | | 95.62% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001435049_256x256.png) | 137 | CHINOOK THERAPEUTICS INC. | | 92.00% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001133818_256x256.png) | 138 | BIO-PATH HOLDINGS INC | | 91.91% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001393434_256x256.png) | 139 | OCULAR THERAPEUTIX INC | | 91.51% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001583648_256x256.png) | 140 | PIERIS PHARMACEUTICALS INC. | | 91.21% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001355790_256x256.png) | 141 | International Stem Cell CORP | | 91.01% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001281895_256x256.png) | 142 | ROCKET PHARMACEUTICALS INC. | | 89.16% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 143 | ARQULE INC | | 87.69% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000059478_256x256.png) | 144 | ELI LILLY & Co | | 83.84% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001367083_256x256.png) | 145 | Sonoma Pharmaceuticals Inc. | | 83.35% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001420720_256x256.png) | 146 | iBio Inc. | | 77.56% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001582554_256x256.png) | 147 | Matinas BioPharma Holdings Inc. | | 75.29% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001383701_256x256.png) | 148 | Histogen Inc. | | 71.90% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001510964_256x256.png) | 149 | CV Sciences Inc. | | 71.54% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 150 | Molecular Templates Inc. | | 70.60% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001178253_256x256.png) | 151 | SCYNEXIS INC | | 70.55% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001053369_256x256.png) | 152 | ELITE PHARMACEUTICALS INC NV | | 70.42% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001098880_256x256.png) | 153 | IntelGenx Technologies Corp. | | 69.58% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000057725_256x256.png) | 154 | LANNETT CO INC | | 67.16% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001609809_256x256.png) | 155 | Seres Therapeutics Inc. | | 66.14% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001566373_256x256.png) | 156 | F-star Therapeutics Inc. | | 64.84% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001061027_256x256.png) | 157 | Viracta Therapeutics Inc. | | 64.68% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001588972_256x256.png) | 158 | Societal CDMO Inc. | | 63.16% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001029142_256x256.png) | 159 | DYNAVAX TECHNOLOGIES CORP | | 62.44% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000849146_256x256.png) | 160 | Lifevantage Corp | | 61.17% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 161 | SOPHIRIS BIO INC. | | 59.00% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001401667_256x256.png) | 162 | PUMA BIOTECHNOLOGY INC. | | 57.45% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001585364_256x256.png) | 163 | PERRIGO Co plc | | 56.94% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001429260_256x256.png) | 164 | Fortress Biotech Inc. | | 55.25% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 165 | Teligent Inc. | | 54.71% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001454789_256x256.png) | 166 | Astria Therapeutics Inc. | | 54.42% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 167 | CELGENE CORP DE | | 53.16% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001285819_256x256.png) | 168 | OMEROS CORP | | 51.18% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001390478_256x256.png) | 169 | SELLAS Life Sciences Group Inc. | | 50.00% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001048477_256x256.png) | 170 | BIOMARIN PHARMACEUTICAL INC | | 49.91% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001555280_256x256.png) | 171 | Zoetis Inc. | | 49.41% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001388320_256x256.png) | 172 | Actinium Pharmaceuticals Inc. | | 49.19% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001501989_256x256.png) | 173 | CytomX Therapeutics Inc. | | 47.60% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001410098_256x256.png) | 174 | CorMedix Inc. | | 46.21% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001497504_256x256.png) | 175 | PLx Pharma Winddown Corp. | | 46.07% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001429560_256x256.png) | 176 | TREVENA INC | | 42.82% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001069899_256x256.png) | 177 | PHIBRO ANIMAL HEALTH CORP | | 41.28% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001267813_256x256.png) | 178 | MARINUS PHARMACEUTICALS INC. | | 40.09% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 179 | Impax Laboratories LLC | | 39.87% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000704562_256x256.png) | 180 | Avid Bioservices Inc. | | 39.46% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001106838_256x256.png) | 181 | Sonnet BioTherapeutics Holdings Inc. | | 36.89% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 182 | Axsome Therapeutics Inc. | | 36.10% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001124105_256x256.png) | 183 | GYRE THERAPEUTICS INC. | | 35.59% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001340652_256x256.png) | 184 | ChemoCentryx Inc. | | 35.01% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 185 | Bellerophon Therapeutics Inc. | | 34.49% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 186 | Tonix Pharmaceuticals Holding Corp. | | 32.26% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001460602_256x256.png) | 187 | Orgenesis Inc. | | 32.06% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000748592_256x256.png) | 188 | Eterna Therapeutics Inc. | | 27.96% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 189 | PORTOLA PHARMACEUTICALS INC | | 25.46% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 190 | Old API Wind-down Ltd. | | 22.93% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001590560_256x256.png) | 191 | uniQure N.V. | | 22.85% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001270073_256x256.png) | 192 | INTERCEPT PHARMACEUTICALS INC. | | 22.15% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001505512_256x256.png) | 193 | Regulus Therapeutics Inc. | | 20.13% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 194 | VIVUS INC | | 18.34% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001012477_256x256.png) | 195 | AVADEL PHARMACEUTICALS PLC | | 13.65% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 196 | Fibrocell Science Inc. | | 12.48% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001178711_256x256.png) | 197 | Paratek Pharmaceuticals Inc. | | 11.50% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000874015_256x256.png) | 198 | IONIS PHARMACEUTICALS INC | | 8.84% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 199 | Rezolute Inc. | | 2.36% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001576263_256x256.png) | 200 | Mirati Therapeutics Inc. | | -0.10% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000906709_256x256.png) | 201 | NEKTAR THERAPEUTICS | | -0.39% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001641489_256x256.png) | 202 | vTv Therapeutics Inc. | | -2.72% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 203 | SteadyMed Ltd. | | -5.97% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001517022_256x256.png) | 204 | Akebia Therapeutics Inc. | | -6.99% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001389545_256x256.png) | 205 | NovaBay Pharmaceuticals Inc. | | -7.92% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 206 | Viking Therapeutics Inc. | | -8.54% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 207 | Capstone Therapeutics Corp. | | -13.30% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001368148_256x256.png) | 208 | ATHERSYS INC NEW | | -15.93% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001467154_256x256.png) | 209 | NVN Liquidation Inc. | | -16.96% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001476963_256x256.png) | 210 | NightHawk Biosciences Inc. | | -18.31% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001447028_256x256.png) | 211 | Arbutus Biopharma Corp | | -20.06% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001415684_256x256.png) | 212 | MusclePharm Corp | | -32.48% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001360214_256x256.png) | 213 | HARROW INC. | | -33.39% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001595097_256x256.png) | 214 | Corbus Pharmaceuticals Holdings Inc. | | -34.68% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001551986_256x256.png) | 215 | 9 METERS BIOPHARMA INC. | | -37.04% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001082038_256x256.png) | 216 | DURECT CORP | | -41.24% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001001316_256x256.png) | 217 | TG THERAPEUTICS INC. | | -44.94% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 218 | Corium International Inc. | | -48.38% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 219 | Altrazeal Life Sciences Inc. | | -49.38% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001130598_256x256.png) | 220 | Onconova Therapeutics Inc. | | -52.51% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001401914_256x256.png) | 221 | Dare Bioscience Inc. | | -53.82% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 222 | ZEVRA THERAPEUTICS INC. | | -54.84% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001385818_256x256.png) | 223 | AYTU BIOPHARMA INC | | -56.13% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000897448_256x256.png) | 224 | AMARIN CORP PLC\UK | | -59.42% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000891293_256x256.png) | 225 | CTI BIOPHARMA CORP | | -65.02% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 226 | OncoMed Pharmaceuticals Inc | | -68.89% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000786947_256x256.png) | 227 | ACURA PHARMACEUTICALS INC | | -69.86% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 228 | Zyla Life Sciences | | -72.55% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001016504_256x256.png) | 229 | INTEGRATED BIOPHARMA INC | | -73.24% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001411906_256x256.png) | 230 | Ampio Pharmaceuticals Inc. | | -75.42% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001355250_256x256.png) | 231 | Innovation Pharmaceuticals Inc. | | -77.83% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 232 | EOM Pharmaceutical Holdings Inc. | | -83.47% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 233 | ARRAY BIOPHARMA INC | | -84.15% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000855654_256x256.png) | 234 | ImmunoGen Inc. | | -84.23% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000899460_256x256.png) | 235 | MANNKIND CORP | | -95.60% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001466301_256x256.png) | 236 | Clovis Oncology Inc. | | -97.02% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001574235_256x256.png) | 237 | Pulmatrix Inc. | | -104.00% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001124524_256x256.png) | 238 | Cryoport Inc. | | -105.14% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 239 | Neos Therapeutics Inc. | | -106.28% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001325879_256x256.png) | 240 | AVEO PHARMACEUTICALS INC. | | -106.88% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 241 | Theriva Biologics Inc. | | -111.98% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 242 | MABVAX THERAPEUTICS HOLDINGS INC. | | -115.10% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001587221_256x256.png) | 243 | Zosano Pharma Corp | | -118.51% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001174940_256x256.png) | 244 | ORAGENICS INC | | -120.17% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 245 | KERYX BIOPHARMACEUTICALS INC | | -120.48% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 246 | GT Biopharma Inc. | | -121.39% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001372514_256x256.png) | 247 | KIORA PHARMACEUTICALS INC | | -140.55% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001160308_256x256.png) | 248 | Savara Inc | | -148.02% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 249 | HypGen Inc | | -148.70% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001010086_256x256.png) | 250 | SIGA TECHNOLOGIES INC | | -175.28% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 251 | PROTEO INC | | -180.51% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 252 | NORTHWEST BIOTHERAPEUTICS INC | | -188.66% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 253 | Anthera Pharmaceuticals Inc | | -196.08% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001348362_256x256.png) | 254 | Lexaria Bioscience Corp. | | -215.45% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001460702_256x256.png) | 255 | Qualigen Therapeutics Inc. | | -218.45% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 256 | ProtoKinetix Inc. | | -228.18% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 257 | CQENS Technologies Inc. | | -237.11% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001014763_256x256.png) | 258 | Ainos Inc. | | -237.78% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 259 | RENOVARO BIOSCIENCES INC. | | -238.04% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001017491_256x256.png) | 260 | SEELOS THERAPEUTICS INC. | | -240.73% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000791908_256x256.png) | 261 | XOMA Corp | | -257.70% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 262 | REGENERX BIOPHARMACEUTICALS INC | | -261.97% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000818033_256x256.png) | 263 | HERON THERAPEUTICS INC. DE | | -268.46% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 264 | MERRIMACK PHARMACEUTICALS INC | | -282.56% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001653821_256x256.png) | 265 | CEN BIOTECH INC | | -283.69% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 266 | NANOMIX Corp | | -307.04% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 267 | CARDAX INC. | | -314.36% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001615999_256x256.png) | 268 | NEUROPATHIX INC. | | -333.35% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001422142_256x256.png) | 269 | Aadi Bioscience Inc. | | -365.91% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001385508_256x256.png) | 270 | OPIANT PHARMACEUTICALS INC. | | -375.66% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 271 | Health-Right Discoveries Inc. | | -383.95% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 272 | Rebus Holdings Inc. | | -386.07% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001585608_256x256.png) | 273 | Jaguar Health Inc. | | -395.70% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 274 | Q BioMed Inc. | | -429.10% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000822370_256x256.png) | 275 | Emmaus Life Sciences Inc. | | -440.65% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 276 | PROVECTUS BIOPHARMACEUTICALS INC. | | -476.22% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001530746_256x256.png) | 277 | Kaya Holdings Inc. | | -502.50% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 278 | ARTELO BIOSCIENCES INC. | | -509.30% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 279 | ACTAVIA LIFE SCIENCES INC. | | -512.43% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 280 | Skye Bioscience Inc. | | -536.33% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 281 | LIXTE BIOTECHNOLOGY HOLDINGS INC. | | -541.47% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000832489_256x256.png) | 282 | GeoVax Labs Inc. | | -583.28% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 283 | BIOXYTRAN INC | | -607.50% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 284 | RespireRx Pharmaceuticals Inc. | | -626.68% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001173313_256x256.png) | 285 | ABVC BIOPHARMA INC. | | -652.82% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001559356_256x256.png) | 286 | Biostax Corp. | | -765.59% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 287 | Propanc Biopharma Inc. | | -830.88% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 288 | United Cannabis Corp | | -894.55% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 289 | Regen BioPharma Inc | | -1429.50% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001642375_256x256.png) | 290 | Guardion Health Sciences Inc. | | -1458.67% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001411685_256x256.png) | 291 | Vistagen Therapeutics Inc. | | -2111.90% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 292 | Oncolix Inc. | | -4571.69% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |